As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

The following is the full transcript of an interview with Dr. Peter Marks, former head of FDA's Center for Biologics Evaluation and Research, a portion of which aired on "Face the Nation with Margaret ...

Years after helping drive the first Trump administration’s efforts to develop a Covid vaccine, Dr. Peter Marks resigned as the Food and Drug Administration’s leading official overseeing ...

The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine regulator Dr. Peter Marks, openly worrying that his exit portends an ...

Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from ...

"To dismiss children's deaths due to infectious diseases that are preventable by vaccines as just expected or not a big deal, that's just not acceptable to me," said Dr. Peter Marks, in an ...

March 29 (UPI) --Dr. Peter Marks, the top vaccine regulator at the U.S. Food and Drug Administration, was forced to resign, citing Health and Human Services Secretary Robert F. Kennedy Jr.'s ...

Dr. Peter Marks, the Food and Drug Administration's top vaccine official, was forced to resign Friday, multiple people familiar with the matter told CBS News. An official with the Department of ...

Dr Peter Marks, the director for the agency’s Center for Biologics Evaluation and Research, submitted his resignation letter to FDA Acting Commissioner Sara Brenner, citing Health and Human ...

Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, has resigned, according to a resignation letter obtained by CNBC. Marks in his letter cites "misinformation and lies" ...

WASHINGTON - Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter on Friday that he was resigning from his position and criticized Health and Human ...

Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.